hep3b cells (CLS Cell Lines Service GmbH)
CLS Cell Lines Service GmbH is a verified supplier 
CLS Cell Lines Service GmbH manufactures this product 
90
Structured Review
CLS Cell Lines Service GmbH
hep3b cells
Hep3b Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hep3b+cells/HEP3B+Cells/custom%40305141%4010%2E64898%2F2026%2E05%2E15%2E725527
Average 90 stars, based on 8 article reviews
Hep3b Cells, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hep3b+cells/HEP3B+Cells/custom%40305141%4010%2E64898%2F2026%2E05%2E15%2E725527
Average 90 stars, based on 8 article reviews
hep3b cells - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Expressing:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from Modification:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from Cell Culture:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from Control:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from Staining:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from High Content Screening:Article Title: Pharmacological inhibition of deubiquitinase UCH-L1 by LDN57444 sensitises hepatocellular carcinoma to sorafenib by reverting drug-induced adaptive responses Article Snippet: PrePrint: to quantify UCH-L1 expression reported as log2 fold changes with Benjamini–Hochberg adjusted p-values to control the FDR. The human liver cancer cell line Hep 3B2.1-7 (ATCC HB-8064) was purchased from |
